U.S. patent application number 10/289479 was filed with the patent office on 2003-04-17 for bioabsorbable, biocompatible polymers for tissue engineering.
This patent application is currently assigned to Tepha, Inc.. Invention is credited to Williams, Simon F..
Application Number | 20030072784 10/289479 |
Document ID | / |
Family ID | 22405001 |
Filed Date | 2003-04-17 |
United States Patent
Application |
20030072784 |
Kind Code |
A1 |
Williams, Simon F. |
April 17, 2003 |
Bioabsorbable, biocompatible polymers for tissue engineering
Abstract
Bioabsorbable biocompatible polymers which provide a good match
between their properties and those of certain tissue structures are
provided. The bioabsorbable biocompatible polymers can be prepared
with tensile strengths, elongation to breaks, and/or tensile
modulus (Young's modulus) values of the tissues of the
cardiovascular, gastrointestinal, kidney and genitourinary,
musculoskeletal, and nervous systems, as well as those of the oral,
dental, periodontal, and skin tissues. Methods for processing the
bioabsorbable biocompatible polymers into tissue engineering
devices are also provided.
Inventors: |
Williams, Simon F.;
(Sherborn, MA) |
Correspondence
Address: |
PATREA L. PABST
HOLLAND & KNIGHT LLP
SUITE 2000, ONE ATLANTIC CENTER
1201 WEST PEACHTREE STREET, N.E.
ATLANTA
GA
30309-3400
US
|
Assignee: |
Tepha, Inc.
|
Family ID: |
22405001 |
Appl. No.: |
10/289479 |
Filed: |
November 6, 2002 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10289479 |
Nov 6, 2002 |
|
|
|
09518123 |
Mar 3, 2000 |
|
|
|
6514515 |
|
|
|
|
60122827 |
Mar 4, 1999 |
|
|
|
Current U.S.
Class: |
424/426 ;
442/123 |
Current CPC
Class: |
A61L 31/06 20130101;
A61L 27/18 20130101; Y10T 442/2525 20150401; A61L 31/06 20130101;
C08L 67/04 20130101; A61L 27/18 20130101; C08L 67/04 20130101 |
Class at
Publication: |
424/426 ;
442/123 |
International
Class: |
A61F 002/00; B32B
027/12 |
Claims
I claim:
1. A composition or device for use in tissue engineering comprising
a bioabsorbable biocompatible polymer comprising
polyhydroxyalkanoate, wherein the polymer has one or more
mechanical properties selected from the group consisting of stress,
strain, stress-strain, stress-strain hysteresis, stress-strain
relaxation, viscoelasticity, contraction stress, resting stress,
Young's modulus, tensile strength, durability, yield point, failure
strength, toughness, ductility, softness, hardness, creep, elastic
deformation, wear resistance, shear failure, roughness, compressive
strength, load capacity, modulus of elasticity, ultimate
compressive strength, yield strength, stress-strain relationship,
scratch resistance, abrasion resistance, flexural modulus, shear
modulus, contact angle, surface tension, adhesive strength, surface
free energy, bending strength, shear strength, bonding strength,
bending strength, bending stiffness, compressive modulus, bending
modulus, fracture toughness, elongation, fiber strength, fiber
modulus, fiber elongation, thermal expansion coefficient, fracture
toughness, static and dynamic elasticity, longitudinal stretch,
stress, and strain, radial stretch, stress and strain,
circumferential stretch, stress and strain, ultimate elongation,
viscosity, expansion, static and kinetic coefficients of friction,
plasticity, axial tension, shock absorbance, bearing strength,
formability, rigidity, stress rupture, bend radius, impact
strength, and fatigue strength, equivalent to the same properties
of a differentiated tissue or tissue structure, wherein the polymer
comprises polyhydroxyalkanoate.
2. The composition of claim 1 wherein the polymer degrades in vivo
in less than one year.
3. The composition of claim 1 wherein the polymer has an extension
to break of over 25%.
4. The composition of claim 3 wherein the polymer is in the form of
a fiber and the extension to break is over 45%.
5. The composition of claim 1 wherein the polymer has a tensile
strength less than 10,000 psi.
6. The polymer of claim 5 wherein the polymer is in the form of a
fiber and the tensile strength is less than 50,000 psi.
7. The composition of claim 1 wherein the polymer has a Youngs
modulus of less than 100,000 psi.
8. The polymer of claim 7 wherein the polymer is in the form of a
fiber and the Youngs modulus is less than 200,000 psi.
9. The composition of claim 1 wherein the polymer has a melting
temperature less than 190.degree. C.
10. The composition of claim 1 wherein the polymer has a glass
transition temperature less than 20.degree. C.
11. The composition of claim 1 wherein the polymer has two or more
properties selected from the group consisting of extension to break
over 25%, tensile strength less than 10,000 psi, Youngs modulus
less than 100,000 psi, glass transition less than 20.degree. C.,
and melting temperature less than 190.degree. C.
12. The composition of claim 1 wherein the tissue is selected from
the group consisting of cardiovascular, gastrointestinal, kidney,
genitourinary, musculoskeletal, nervous, oral, breast, periodontal,
and skin.
13. The composition of claim 1 wherein the mechanical property is
selected from the group consisting of tensile strength, Youngs
modulus, elongation to break, hardness, compressive strength, burst
strength, toughness, and impact strength.
14. The composition of claim 1 wherein the tissue is cartilage and
the polymer has a tensile strength of 435 psi.+-.125%.
15. The composition of claim 1 wherein the tissue is skin and the
polymer has a tensile strength of 1,100 psi.+-.25%.
16. The composition of claim 1 wherein the tissue is tendon and the
polymer has a tensile strength of 7,700 psi.+-.25%.
17. The composition of claim 1 wherein the tissue is aorta and the
polymer has a tensile strength of 160 psi.+-.25%.
18. The composition of claim 1 wherein the tissue is cardiac muscle
and the polymer has a tensile strength of 16 psi.+-.25%.
19. The composition of claim 1 wherein the tissue is bone and a
polymer has a tensile strength of 10,000 psi.+-.25%.
20. The composition of claim 1 wherein the tissue is enamel and the
polymer has a tensile strength of 1,600 psi.+-.25%.
21. The composition of claim 1 wherein the tissue is skin and the
polymer has an ultimate elongation of 78%.+-.25%.
22. The composition of claim 1 wherein the tissue is tendon and the
polymer has an ultimate elongation of 10%.+-.25%.
23. The composition of claim 1 wherein the tissue is cartilage and
polymer has an ultimate elongation of 30%.+-.25%.
24. The composition of claim 1 wherein the tissue is heart and the
polymer has an ultimate elongation of 10-15%.+-.25%.
25. The composition of claim 1 wherein the tissue is aorta and the
polymer has an ultimate elongation in the transverse and
longitudinal directions of 77-81%.+-.25%.
26. The composition of claim 1 wherein the tissue is skin and the
polymer has a Youngs modulus of 2,000-18,000 psi.+-.25%.
27. A device comprising a bioabsorbable biocompatible polymer with
one of more mechanical properties equivalent to a specific tissue
or tissue structure, wherein the device is selected from the group
consisting of a tissue engineering scaffold, guided tissue repair
material, wound dressing, drug delivery vehicle, anti-adhesion
material, cell encapsulation material, coating, implant, stent,
orthopaedic device, prosthetic, adhesive, diagnostic, sutures,
surgical meshes, staples, meniscus repair and regeneration devices,
screws (interference screws and meniscal screws), bone plates and
plating systems, cardiovascular patches, pericardial patches,
slings, pins, anti-adhesion barriers, articular cartilage repair
devices, nerve guides, tendon and ligament repair devices, atrial
septal defect pathces, bulking and filling agents, vein valves,
bone marrow scaffolds, bone graft scaffolds, skin substitutes,
dural substitutes, ocular implants, spinal fusion cages, and
muscular implants (cardiac and skelatal).
28. The device of claim 27 wherein the device is a tissue
engineering scaffold or matrix.
29. The device of claim 28 wherein the polymer degrades in vivo in
less than two years.
30. The device of claim 28 wherein the tissue engineering scaffold
which has different properties in different regions.
31. The device of claim 28 wherein the scaffold or matrix is
flexible.
32. The device of claim 28 wherein the tissue is heart valve or
blood vessel.
33. The device of claim 28 wherein the tissue engineering scaffold
or matrix is for tissue engineering of musculoskeletal tissue.
34. The device of claim 28 wherein the tissue is selected from the
group consisting of cartilage, tendon, ligament, and bone.
35. The device of claim 28 wherein the tissue engineering scaffold
or matrix is for tissue engineering of genitourinary tissue.
36. The device of claim 28 wherein the tissue forms a structure
selected from the group consisting of bladder, ureter, and
urethra.
37. The device of claim 28 for tissue engineering of gingiva.
38. The device of claim 28 seeded with cells for implantation.
39. The device of claim 28 further comprising materials selected
from the group consisting of other polymers, compounds, additives,
biologically active substances, growth factors, cell attachment
factors, and drugs.
40. A method for producing a bioabsorbable biocompatible polymer
composition comprising: selecting a tissue structure and measuring
one or more mechanical properties selected from the group
consisting of stress, strain, stress-strain, stress-strain
hysteresis, stress-strain relaxation, viscoelasticity, contraction
stress, resting stress, Young's modulus, tensile strength,
durability, yield point, failure strength, toughness, ductility,
softness, hardness, creep, elastic deformation, wear resistance,
shear failure, roughness, compressive strength, load capacity,
modulus of elasticity, ultimate compressive strength, yield
strength, stress-strain relationship, scratch resistance, abrasion
resistance, flexural modulus, shear modulus, contact angle, surface
tension, adhesive strength, surface free energy, bending strength,
shear strength, bonding strength, bending strength, bending
stiffness, compressive modulus, bending modulus, fracture
toughness, elongation, fiber strength, fiber modulus, fiber
elongation, thermal expansion coefficient, fracture toughness,
static and dynamic elasticity, longitudinal stretch, stress, and
strain, radial stretch, stress and strain, circumferential stretch,
stress and strain, ultimate elongation, viscosity, expansion,
static and kinetic coefficients of friction, plasticity, axial
tension, shock absorbance, bearing strength, formability, rigidity,
stress rupture, bend radius, impact strength, and fatigue strength,
equivalent to the same properties of a differentiated tissue or
tissue structure, and selecting from a combination of monomers that
can be polymerized to make a polymer, one or more monomers which
when linked in a polymeric form, have the mechanical property or
properties of the tissue or tissue structure.
41. The method of claim 40 wherein the tissue structure is selected
from the group consisting of cardiovascular structures including
heart valves and blood vessels, gastrointestinal structures,
kidney, genitourinary structures including bladder, ureter, and
urethra, musculoskeletal structures including bone, cartilage,
tendon, and ligament, nervous system structures, oral tissues,
periodontal tissues, and skin tissue.
42. The method of claim 40 wherein the monomers are selected from
hydroxy acids.
43. The method of claim 40 wherein the polymer is selected from the
group consisting of polyester, poly(orthoester), polyanhydride,
polyphosphazene, polyesteramide, polypeptide, polyamide,
polydihydropyran, and polycyanoacrylate.
44. The method of claim 40 wherein the polymercontains one or more
linkages selected from the group consisting of ester, amide,
urethane, carbonate, iminocarbonate, oxalate, oxamate, orthoester,
anhydride, phosphazene, glycoside, and ether linkages.
Description
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] Priority is claimed to U.S. provisional application Serial
No. 60/122,827, filed Mar. 4, 1999.
FIELD OF THE INVENTION
[0002] The present invention generally relates to bioabsorbable,
biocompatible polymers and methods for making devices for tissue
engineering and tissue regeneration from these materials.
BACKGROUND TO THE INVENTION
[0003] During the last 20 to 30 years, several bioabsorbable,
biocompatible polymers have been developed for use in medical
devices, and approved for use by the U.S. Food and Drug
Administration (FDA). These FDA approved materials include
polyglycolic acid (PGA), polylactic acid (PLA), Polyglactin 910
(comprising a 9:1 ratio of glycolide per lactide unit, and known
also as VICRYL.TM.), polyglyconate (comprising a 9:1 ratio of
glycolide per trimethylene carbonate unit, and known also as
MAXON.TM.), and polydioxanone (PDS). In general, these materials
biodegrade in vivo in a matter of months, although certain more
crystalline forms biodegrade more slowly. These materials have been
used in orthopedic applications, wound healing applications, and
extensively in sutures after processing into fibers. More recently,
some of these polymers also have been used in tissue engineering
applications.
[0004] Tissue engineering has emerged as a multi-disciplinary field
combining biology, materials science, and surgical reconstruction,
to provide living tissue products that restore, maintain, or
improve tissue function. The need for this approach has arisen
primarily out of a lack of donor organs and tissues, but also
because it offers the promise of being able to dramatically expand
the ability to repair tissues and develop improved surgical
procedures.
[0005] In general, three distinct approaches currently are used to
engineer new tissue. These are (1) infusion of isolated cells or
cell substitutes, (2) use of tissue inducing materials and/or
tissue regeneration scaffolds (sometimes referred to as guided
tissue repair), and (3) implantation of cells seeded in scaffolds
(either prior to or subsequent to implantation). In the third case,
the scaffolds may be configured either in a closed manner to
protect the implanted cells from the body's immune system, or in an
open manner so that the new cells can be incorporated into the
body.
[0006] In open scaffold systems and guided tissue repair, tissue
engineering devices have normally been fabricated from natural
protein polymers such as collagen, or from the synthetic polymers
listed above, which in both cases degrade over time and are
replaced by new tissue. While some of these materials have proven
to be good substrates for cell and tissue growth, and provide good
scaffolding to guide and organize the regeneration of certain
tissues, they often do not have the specific mechanical
requirements that the scaffold needs to provide until the new
tissue is developed and able to take over these functions. These
materials may also be difficult to process and fabricate into the
desired form, handle poorly in the operating room, be difficult to
suture, and sometimes fall apart prematurely. For example, it has
been reported that tissue engineered heart valve leaflet scaffolds
derived from polyglactin and PGA are too stiff and cause severe
pulmonary stenosis when implanted in sheep (Shinoka, et al., "New
frontiers in tissue engineering: tissue engineered heart valves" in
Synthetic Bioabsorbable Polymer Scaffolds (Atala & Mooney,
eds.) pp. 187-98 (Birkhauser, Boston, 1997)).
[0007] FIG. 1, which plots the tensile strength and elongation to
break values for representative FDA approved (compression molded)
bioabsorbable biocompatible polymers against these values for
different tissue structures, reveals a significant mismatch between
the mechanical properties of these polymers and the different
tissue structures. In particular, it is apparent that the existing
bioabsorbable biocompatible polymers are stiff, inelastic
materials, with elongations to break of around 25%, yet many
tissues are much more flexible, elastic, and have longer elongation
to break values. Accordingly, the biomaterial products currently
used in temporary scaffolds for regenerating human tissues do not
exhibit the same multi-axial physical and mechanical properties as
native tissues, which are hierarchical, three-dimensional
structures (see abstract of an award by the Advanced Technology
Program to Johnson and Johnson Corporate Biomaterials Center,
October 1997).
[0008] Attempts have been made to develop new bioabsorbable
biocompatible polymers with more flexible, elastomeric properties.
One approach has been to incorporate lactide or glycolide and
caprolactone joined by a lysine-based diisocyante into a
polyurethane (Lamba, et al., "Degradation of polyurethanes" in
Polyurethanes in Biomedical Applications, pp. 199-200 (CRC Press
LLC, Boca Raton, Fla., 1998). However, these crosslinked
polyurethane networks cannot be processed by standard techniques
such as solution casting or melt processing, limiting their
usefulness. There is also no evidence that the polyurethane
segments are completely biodegraded in vivo. A commercial material,
known as TONE.TM., has also been evaluated as an elastomeric
implant material. However, this material degrades in vivo very
slowly, and therefore has limited application (Perrin, et al.,
"Polycaprolactone" in Handbook of Bioabsorbable Polymers (Domb, et
al., eds.) pp. 63-76 (Harwood, Amsterdam, 1997)). Another approach
has been to synthesize protein-based polymers, particularly
polymers containing elastomeric polypeptide sequences (Wong, et
al., "Synthesis and properties of bioabsorbable polymers used as
synthetic matrices for tissue engineering" in Synthetic
Bioabsorbable Polymer Scaffolds (Atala & Mooney, eds.) pp.
51-82 (Birkhauser, Boston, 1997). However, these materials are not
reported to biodegrade in vivo, although cells can invade matrices
derived from these materials. They also lack the advantages of
thermoplastic polymers in fabrication of devices.
[0009] U.S. Pat. Nos. 5,468,253 and 5,713,920, both to Bezwada et
al., disclose bioabsorbable elastomeric materials which are used to
form devices that, based on in vitro data, are alleged to
completely bioabsorb within one year or six months. However,
deGroot et al., Biomaterials, 18:613-22 (1997) provides in vivo
data for these materials and reports that the implanted material
fragmented after 56 weeks into white crystalline-like fragments. It
is suspected that these fragments are crystalline poly-L-lactide,
which is very slow to degrade. Nonetheless, whatever the
composition of the fragments, the material is not completely
bioabsorbed after one year in vivo. These materials also typically
are difficult to process and may have poor shelf stability.
[0010] Thus, while the current bioabsorbable biocompatible polymers
offer a range of useful properties for certain medical
applications, it is desirable to develop methods to prepare
bioabsorbable biocompatible polymers that significantly extend the
range of properties available. It would thus be desirable to
develop methods for preparing bioabsorbable biocompatible polymers
with mechanical properties closer to those of tissue, particularly
soft tissues. It would also be desirable to develop methods for
making bioabsorbable biocompatible materials which can be readily
processed, and fabricated into tissue engineering devices that can
be easily implanted.
[0011] It is therefore an object of this invention to provide
methods for preparing bioabsorbable biocompatible polymers with
mechanical properties that provide a better match with those of
tissue structures.
[0012] It is a further object of this invention to provide new
compositions with mechanical properties that provide a better match
with those of tissue structures.
[0013] It is another object of this invention to provide methods
for fabricating devices from these compositions.
SUMMARY OF THE INVENTION
[0014] Bioabsorbable biocompatible polymers are selected based on
their physical and/or mechanical properties to correspond to the
physical properties of tissues to be regenerated or constructed.
Physical properties include elasticity, strength, flexibility, and
processibility. These properties can be measured by determining
factors such as tensile strength, elongation or extension to break,
and Youngs modulus. In a preferred embodiment, the polymers have an
extension to break over 25%, tensile strength less than 10,000 psi,
Youngs modulus less than 100,000 psi, glass transition temperature
less than 20.degree. C., and melting temperature less than
190.degree. C. In one embodiment, the bioabsorbable biocompatible
polymers can be prepared with tensile strengths equivalent to the
tensile strengths of the tissues of the cardiovascular,
gastrointestinal, kidney and genitourinary, musculoskeletal, and
nervous systems, as well as those of the oral, dental, periodontal,
and skin tissues. In another embodiment, the bioabsorbable
biocompatible polymers can be prepared with elongations to break
equivalent to the elongations to break of the same tissues. In
still another embodiment, the bioabsorbable biocompatible polymers
can be prepared with tensile modulus (Young's modulus) values
equivalent to these tissues.
[0015] Methods for processing the bioabsorbable biocompatible
polymers into tissue engineering devices are also described.
BRIEF DESCRIPTION OF THE DRAWINGS
[0016] FIG. 1 is a graph comparing the mechanical properties of
PGA, PLA, polyglactin, polyglyconate, and polydioxanone with those
of different tissue structures.
[0017] FIG. 2 is a graph comparing the mechanical properties of
bioabsorbable polymers described herein with the mechanical
properties of different tissues or tissue structures.
DETAILED DESCRIPTION OF THE INVENTION
[0018] Polymers are provided which are bioabsorbable,
biocompatible, and have mechanical properties similar to the
physical and/or mechanical properties of tissue structures,
including stress, strain, stress-strain, stress-strain hysteresis,
stress-strain relaxation, viscoelasticity, contraction stress,
resting stress, Young's modulus, tensile strength, durability,
yield point, failure strength, toughness, ductility, softness,
hardness, creep, elastic deformation, wear resistance, shear
failure, roughness, compressive strength, load capacity, modulus of
elasticity, ultimate compressive strength, yield strength,
stress-strain relationship, scratch resistance, abrasion
resistance, flexural modulus, shear modulus, contact angle, surface
tension, adhesive strength, surface free energy, bending strength,
shear strength, bonding strength, bending strength, bending
stiffness, compressive modulus, bending modulus, fracture
toughness, elongation, fiber strength, fiber modulus, fiber
elongation, thermal expansion coefficient, fracture toughness,
static and dynamic elasticity, longitudinal stretch, stress, and
strain, radial stretch, stress and strain, circumferential stretch,
stress and strain, ultimate elongation, viscosity, expansion,
static and kinetic coefficients of friction, plasticity, axial
tension, shock absorbance, bearing strength, formability, rigidity,
stress rupture, bend radius, impact strength, and fatigue strength.
In a preferred embodiment, the polymers have elongations to break
of more than 25%, and/or tensile modulus values less than 500,000
psi. In another preferred embodiment, the polymers are fabricated
into medical devices using standard polymer processing techniques,
and used as tissue engineering devices to provide living tissue
products that restore, maintain, or improve tissue function, for
example, in the cardiovascular, gastrointestinal, kidney and
genitourinary, musculoskeletal, and nervous systems, as well as
those of the oral, dental, periodontal, and skin tissues.
[0019] I. Polymers
[0020] The polymers described herein may be prepared by synthetic
or natural methods. However, the method must provide the desired
polymer in a form sufficiently pure for use as an implantable
material. The polymer should not contain any undesirable residues
or impurities which could elicit an undesirable response either in
vitro in the case of a cell-seeded construct or in vivo.
[0021] The polymers may be prepared from any combination of
monomeric units. These units must, however, be capable of
biodegrading in vivo to nontoxic compounds, which can optionally be
excreted or further metabolized. The combination of units in the
polymer must also be biocompatible, and not elicit an undesirable
biological response upon implantation. The polymer may be
biodegraded in vivo by any means, including hydrolysis, enzymatic
attack, a cell-mediated process, or by any other biologically
mediated process. It is considered desirable for tissue engineering
applications that the polymer scaffold serve as a transitional
construct, and thus be fully degraded once the new tissue is able
to take over the function of the scaffold. Since the rates at which
different new tissues are likely to be able to assume their new
function will vary, it is desirable to have polymers with a range
of degradation rates as well as a range of different properties.
Generally, however, preferred polymers will degrade in a matter of
weeks to months, preferably less than one year, rather than several
years.
[0022] The mechanical properties of the polymer are designed to
meet the needs of the particular tissue engineering application.
Thus, according to the method described herein for preparing
bioabsorbable biocompatible polymers, the monomeric units can be
selected to provide upon combination of the correct ratios of these
monomeric units the desired property or property set. If necessary,
the monomeric units may be combined in a specific order as in, for
example, a block copolymer, or alternatively they can be assembled
in a random manner. They may also be prepared with different
molecular weights to achieve the correct performance.
[0023] In a preferred method as described herein, the monomeric
units are hydroxy acids, and the polymers are polyesters. The
distance between the hydroxy group and the acid group can be small
or large, however, monomers are preferably 2-, 3-, 4-, 5-, or
6-hydroxy acids. The hydroxy acids may optionally contain other
functional groups and be substituted at any position, including
heteroatoms between the hydroxy and acid groups. These hydroxy
acids may be polymerized either using synthetic methods or
preferably using biological methods. In the latter case, the
hydroxy acids may be derived in vivo from a non-hydroxy acid
source.
[0024] Suitable methods for preparing the polyesters are described
in Williams, S. F. and Peoples, O. P. CHEMTECH, 26:38-44 (1996),
Williams, S. F. and Peoples, O. P., Chem. Br., 33:29-32 (1997),
U.S. Pat. No. 4,910,145 to Holmes, P. A. and Lim, G. B.; Byrom, D.,
"Miscellaneous Biomaterials," in D. Byrom, Ed., "Biomaterials"
MacMillan Publishers, London, 1991, pp. 333-59; Hocking, P. J. and
Marchessault, R. H. "Biopolyesters", G. J. L. Griffin, Ed.,
"Chemistry and Technology of Bioabsorbable Polymers," Chapman and
Hall, London, 1994, pp.48-96; Holmes, P. A., "Biologically Produced
(R)-3-hydroxyalkanoate Polymers and Copolymers," in D. C. Bassett
Ed., "Developments in Crystalline Polymers," Elsevier, London, Vol.
2, 1988, pp. 165; Lafferty et al., "Microbial Production of
Poly-.beta.-hydroxybutyric acid," H. J. Rehm and G. Reed, Eds.,
"Biotechnology", Verlagsgesellschaft, Weinheim, Vol. 66, 1988, pp.
135-76; Muller and Seebach, Angew. Chem. Int. Ed. Engl. 32:477-502
(1993); Steinbuchel, A. "Polyhydroxyalkanoic Acids," in D. Byrom
Ed., "Biomaterials", MacMillan Publishers, London, 1991, pp.
123-213; Steinbuchel and Wiese, Appl. Microbiol. Biotechnol.,
37:691-697 (1992); U.S. Pat. Nos. 5,245,023; 5,250,430; 5,480,794;
5,512,669; 5,534,432; Agostini, D. E. et al., Polym. Sci., Part
A-1, 9:2775-87 (1971); Gross, R. A. et al, Macromolecules,
21:2657-68 (1988); Dubois, P. I. et al., Macromolecules, 26:4407-12
(1993); Le Borgne, A. and Spassky, N., Polymer, 30:2312-19 (1989);
Tanahashi, N. and Doi, Y., Macromolecules, 24:5732-33 (1991); Hori,
Y. M. et al., Macromolecules, 26:4388-90 (1993); Kemnitzer, J. E.
et al., Macromolecules, 26:1221-1229 (1993); Hori, Y. M. et al.,
Macromolecules, 26:5533-34 (1993); Hocking, P. J. and Marchessault,
R. H., Polym. Bull., 30:163-70 (1993); Xie, W. et al.,
Macromolecules, 30:6997-98 (1997), U.S. Pat. No. 5,563,239 to
Hubbs, J. C. and Harrison, M. N., and Braunegg, G. et al., J.
Biotechnol. 65:127-61 (1998), and Madison & Huisman, Microb.
Mol. Biol. Rev. 63:21-53 (1999).
[0025] In another preferred method described herein, the
bioabsorbable biocompatible polymers are polyesters including one
or more linkages in the main polymer chain which are not ester
linkages. These linkages should be susceptible to cleavage in vivo.
Suitable non-ester linkages may include amides, urethanes,
carbonates, iminocarbonates, oxalates, oxamates, orthoesters,
anhydrides, phosphazenes, glycosides, and ethers. Incorporation of
such chemistries can be used to alter biodegradation rates, tailor
mechanical, surface, or other properties of the polymer, improve
processibility and handling of the materials, and/or to provide
methods for attachment of other compounds to the polymers.
[0026] The bioabsorbable biocompatible polymers described herein
may optionally be further modified either prior to or subsequent to
fabrication. Representative modifications include derivatization,
surface treatments, coatings, coupling of other compounds
particularly biologically active agents.
[0027] II. Mechanical Properties and Polymer Compositions
[0028] The bioabsorbable biocompatible polymers described herein
may be prepared with mechanical properties that resemble those of
tissue. These properties are achieved by preparing the polymers
with different compositions and ratios of monomeric constituents.
For example, polymers with tensile strengths near or equal to that
of tendon and dentin can be prepared by polymerizing
4-hydroxybutyric acid. By incorporating R-3-hydroxybutyric acid
with 4-hydroxybutyric acid into the same polymer as a random
copolymer, it is possible to prepare a material with a tensile
strength near or equal to that of cortical bone. Using combinations
of R-3-hydroxyoctanoate and R-3-hydroxyhexanoate, it is possible to
prepare a copolymer with a tensile strength near or equal to that
of skin and enamel. Other monomers may be incorporated to increase
or decrease the tensile strengths of the bioabsorbable
biocompatible polymers.
[0029] The elongation to break of the bioabsorbable biocompatible
polymers may also be controlled and tailored to those of tissue in
a similar manner. For example, the homopolymer of
R-3-hydroxybutyric acid has an elongation to break of around 5%,
close to tendon. This elongation to break may be progressively
increased to values for cartilage, cardiac muscle, cardiovascular
tissues, skin, aorta, urological tissue, in fact virtually any
tissue, by incorporating a co-monomer, 4-hydroxybutyric acid, with
R-3-hydroxybutyric acid into a copolymer. A copolymer comprising
3-8% 4-hydroxybutyric acid polymerized with 3-hydroxybutyric acid
has an extension to break of 45% to over 100%, which are similar
values to those of cardiac muscle, skin, urological and
cardiovascular tissues including blood vessels and heart
valves.
[0030] In the same manner, it is also possible to prepare
bioabsorbable biocompatible polymers described herein with a range
of tensile modulus values (Youngs modulus) that match those of
tissue structures. For example, depending upon the age of the
person, skin has a tensile modulus value ranging from about 2,000
psi for young children to around 18,000 psi for older people.
According to the method described herein, it is possible to produce
a copolymer of R-3-hydroxyoctanoic acid and R-3-hydroxyhexanoic
acid with a Youngs modulus value of around 1,000-2,000 psi, and a
copolymer of R-3-hydroxybutyric acid and 4-hydroxybutyric acid with
a Youngs modulus ranging from 3,000 psi to 22,000 psi as the
percentage of 4-hydroxybutyric acid is increased from 78% to 100%.
Other compositions can be used for applications requiring higher
Youngs modulus values. For example, the homopolymer of
R-3-hydroxybutyric acid has a Youngs modulus value of around
500,000 psi.
[0031] Thus, by using combinations of different hydroxy acid
monomers, it is possible to prepare bioabsorbable biocompatible
polymers with a wide range of Youngs modulus values that encompass
different tissue structures.
[0032] By using a similar approach of combining appropriate monomer
units, bioabsorbable biocompatible polymers can be produced that
have other desirable mechanical properties and even desirable
barrier properties that provide a good compliance match with
tissue. Examples of other mechanical properties which can be
prepared according to the method described herein include, but are
not limited to, compressive strength, hardness, burst strength,
impact strength, toughness, as well as other viscoelastic elastic
properties. Examples of desirable barrier properties include water
and fluid barrier properties, moisture vapor barrier properties,
and gas barrier properties.
[0033] In some embodiments, it may be desirable to produce a
bioabsorbable biocompatible polymer with two or more mechanical
properties providing a good compliance match with a specific tissue
structure. For example, tendon has a tensile strength of around
6,000 psi and an elongation to break of 10%. According to the
method described herein, a bioabsorbable biocompatible polymer can
be produced comprising 10% R-3-hydroxypentanoic acid and
R-3-hydroxybutyric acid, with approximately the same tensile
strength of about 6,000 psi and an extension to break of 10% as
tendon. Similarly, other combinations of one, two, or more
monomeric units can be used to provide bioabsorbable biocompatible
polymers with two or more of the desired mechanical properties of a
particular tissue structure.
[0034] III. Fabrication of Bioabsorbable Biocompatible Devices
[0035] The bioabsorbable biocompatible polymer compositions are
useful for preparing a variety of medical devices. Examples of
applications of such devices include tissue engineering scaffold,
guided tissue repair material, wound dressing, drug delivery
vehicle, anti-adhesion material, cell encapsulation material,
coating, implant, stent, orthopaedic device, prosthetic, adhesives,
diagnostics, sutures, surgical meshes, staples, meniscus repair and
regeneration devices, screws (interference screws and meniscal
screws), bone plates and plating systems, cardiovascular patches,
pericardial patches, slings, pins, anti-adhesion barriers,
articular cartilage repair devices, nerve guides, tendon and
ligament repair devices, atrial septal defect pathces, bulking and
filling agents, vein valves, bone marrow scaffolds, bone graft
scaffolds, skin substitutes, dural substitutes, ocular implants,
spinal fusion cages, and muscular implants (cardiac and skelatal).
These materials may be used alone, with additives or in
combinations with themselves or other materials. Additives and
other materials may include those components added for the purpose
of further modification of a particular property or properties,
and/or those components which are biologically active such as cell
attachment factors, growth factors, peptides, antibodies and their
fragments.
[0036] In general, a key advantage described herein is that the
bioabsorbable biocompatible polymers can be processed using
conventional polymer processing techniques. Many of the materials
are thermoplastics, and are thus amenable to standard methods for
processing such materials. Such methods are well known to those
skilled in the art, and include such methods as melt processing,
solvent processing, leaching, foaming, extrusion, injection
molding, compression molding, blow molding, spray drying, extrusion
coating, spinning of fibers and subsequent processing into woven or
non-woven constructs.
[0037] A preferred fabricated form of the compositions is a porous
(fibrous) construct, particularly ones which can be used as tissue
engineering scaffolds, and guided tissue repair meshes and
matrices. This construct or matrix may be derived by any suitable
method, including salt leaching, sublimation, solvent evaporation,
spray drying, foaming, processing of the materials into fibers and
subsequent processing into woven or non-woven devices. Such
constructs can be used in tissue engineering applications of the
tissues of the cardiovascular, gastrointestinal, kidney and
genitourinary, musculoskeletal, and nervous systems, as well as
those of the oral, dental, periodontal, and skin tissues. Examples
of such constructs can be used to prepare tissue engineering
scaffolds for both hard and soft tissues. Representative tissue
types include, but are not limited to, cardiovascular (including
blood vessel, artery, and heart valve), cornea and other ocular
tissues, pancreas, alimentary tract (e.g., esophagus and
intestine), ureter, bladder, skin, cartilage, dental, gingival
tissue, bone, liver, kidney, genital organs (including penis,
urethra, vagina, uterus, clitoris, and testis), nerve, spinal cord,
meniscus, pericardium, muscle (e.g., skeletal), tendon, ligament,
trachea, phalanges and small joints, fetal, and breast.
[0038] A further advantage of some of the compositions described
herein is their ability to be sterilized by radiation sources, in
addition to ethylene oxide. Moreover, certain compositions
described herein have the additional advantage of good shelf
stability, resistance to hydrolysis by water and moisture, and thus
less restrictive packaging needs to exclude moisture after
preparation, fabrication, and during storage.
[0039] Another advantage to using the compositions described herein
is the ability to create three dimensional polymer scaffold systems
with properties in different regions. This can be achieved by
combining the compositions described herein either in different
forms, or combining different compositions to make one or more
forms. For example, a specific composition may be processed into a
fibrous form, and then subsequently processed and combined with
another different fibrous or non-fibrous composition. Such
combinations may be achieved by weaving, melt processing, solvent
processing, coating, and other methods known to those skilled in
the art.
[0040] Those skilled in the art will recognize, or be able to
ascertain using no more than routine experimentation, many
equivalents to the specific embodiments of the invention described
herein. The references cited herein arc hereby incorporated by
reference.
[0041] Modifications and variations of the present invention will
be obvious to those of skill in the art from the foregoing detailed
description. Such modifications and variations are intended to come
within the scope of the following claims.
* * * * *